Kairos Pharma (KAPA) Q1 2025 Earnings

Feb 26Confirmed
Q1 1
Q4 2024
Q1 2025
-0.07
-0.05
-0.03
-0.02

Details

Expected EPS
-0.06
Actual EPS
-0.065
Surprise EPS
-0.01
Surprise Percent
-8.33%

Description

⁨Kairos Pharma⁩ (⁦KAPA⁩) has reported earnings of ⁦-0.065⁩ per share for ⁦Q1 2025⁩.

0 Comments

Share your thoughts